BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 6183880)

  • 21. [Aromatic retinoid (Ro-10) in the treatment of palmoplantar psoriasis pustulosa (author's transl)].
    Deichmann B; Spindeldreier A
    Z Hautkr; 1982 Mar; 57(6):425-8. PubMed ID: 7080591
    [No Abstract]   [Full Text] [Related]  

  • 22. [Changes in serum lipid fractions as a side effect of oral retinoids].
    Gollnick H; Luley C; Schwartzkopff W; Orfanos CE
    Z Hautkr; 1982 Sep; 57(17):1255-67. PubMed ID: 6216675
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Oral administration of aromatic retinoids in the treatment of psoriasis].
    Jakubowicz K; Chetkowska J
    Przegl Dermatol; 1980; 67(3):369-75. PubMed ID: 7433705
    [No Abstract]   [Full Text] [Related]  

  • 24. Etretin therapy for severe psoriasis. Evaluation of initial clinical responses.
    Kingston TP; Matt LH; Lowe NJ
    Arch Dermatol; 1987 Jan; 123(1):55-8. PubMed ID: 2948451
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of etretinate and fish oil in psoriasis therapy. Inhibition of hypertriglyceridemia resulting from retinoid therapy after fish oil supplementation.
    Frati C; Bevilacqua L; Apostolico V
    Acta Derm Venereol Suppl (Stockh); 1994; 186():151-3. PubMed ID: 8073820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acitretin in the treatment of severe psoriasis: a randomized double-blind study comparing acitretin and etretinate.
    Meffert H; Sönnichsen N
    Acta Derm Venereol Suppl (Stockh); 1989; 146():176-7. PubMed ID: 2532846
    [No Abstract]   [Full Text] [Related]  

  • 27. [Etretinate: pro and con. Risk-benefit analysis of systemic retinoid therapy in psoriasis and recent developments: free aromatic acid, arotinoids].
    Gollnick H; Orfanos CE
    Hautarzt; 1985 Jan; 36(1):2-9. PubMed ID: 3156105
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Etretinate in familial pustular psoriasis].
    Schewach-Millet M; Shifer O; Ziv R
    Harefuah; 1986 Sep; 111(5-6):112-3. PubMed ID: 3804054
    [No Abstract]   [Full Text] [Related]  

  • 29. [Unusual side effects in patients with psoriatic erythroderma treated with etretinate (RO 10-9359)].
    Castel T; Castro J; Lecha M; Mascaró JM
    Med Cutan Ibero Lat Am; 1986; 14(2):83-6. PubMed ID: 2943953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Retinoid therapy and phototherapy of psoriasis (author's transl)].
    Schauder S
    Dermatologica; 1981; 162(4):236-42. PubMed ID: 7262380
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Etretinate (Tigason) for skin disease.
    Drug Ther Bull; 1983 Feb; 21(3):9-11. PubMed ID: 6839967
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparison of etretinate (Tigason) and parenteral gold in the treatment of psoriatic arthropathy.
    Seppälä J; Laulainen M; Reunala T
    Clin Rheumatol; 1988 Dec; 7(4):498-503. PubMed ID: 3149925
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is the use of Ro 10-9359 (Tigason) in children justified?
    van der Rhee HJ; van Gelderen HH; Polano MK
    Acta Derm Venereol; 1980; 60(3):274-5. PubMed ID: 6158237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term efficacy of psoriasis vulgaris treatments: analysis of treatment with topical corticosteroid and/or vitamin D3 analog, oral cyclosporin, etretinate and phototherapy over a 35-year period, 1975-2010.
    Akasaka E; Mabuchi T; Manabe Y; Yahagi E; Yamada-Hiruma A; Yamaoka H; Kojima T; Kato M; Ikoma N; Ozawa A; Haruki Y
    J Dermatol; 2013 Apr; 40(4):238-43. PubMed ID: 23330814
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of Etretinate on the neutrophil chemotaxis in pustular psoriasis.
    Pigatto PD; Brugo AM; Finzi AF
    Boll Ist Sieroter Milan; 1982 May; 61(2):112-5. PubMed ID: 7126334
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [New treatment of severe psoriasis-effects of the combination therapy of etretinate (Ro 10-9359) and PUVA or external corticoid (author's transl)].
    Sato A; Takahashi M; Seiji M
    Nihon Hifuka Gakkai Zasshi; 1981 Dec; 91(14):1803-15. PubMed ID: 6977667
    [No Abstract]   [Full Text] [Related]  

  • 37. Influence of a systemically administered aromatic retinoid (Ro 10-9359) on the light sensitivity.
    Ippen H; Hofbauer M; Schauder S
    Derm Beruf Umwelt; 1978; 26(3):88-90. PubMed ID: 754925
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical, ultrastructural and biochemical effects of an aromatic retinoid (etretinate) on psoriasis and Darier's disease.
    Lauharanta J
    Acta Derm Venereol Suppl (Stockh); 1982; 101():1-29. PubMed ID: 6954822
    [No Abstract]   [Full Text] [Related]  

  • 39. Low-dose short-term cyclosporine versus etretinate in psoriasis: improvement of skin, nail, and joint involvement.
    Mahrle G; Schulze HJ; Färber L; Weidinger G; Steigleder GK
    J Am Acad Dermatol; 1995 Jan; 32(1):78-88. PubMed ID: 7822521
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Etretinate therapy in generalized pustular psoriasis (Zumbusch type). Immediate and long-term results.
    Wolska H; Jabłonska S; Langner A; Fraczykowska M
    Dermatologica; 1985; 171(5):297-304. PubMed ID: 3908171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.